AC Immune SA
ACIU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651625
No open-market purchases or sales by AC Immune SA insiders were filed in the last 90 days; 43 institutions reported holding it in 13F filings for Q2 2026, worth $58.2M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding AC Immune SA changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 28 | 32 | +4 |
| Shares | 16.0M | 29.6M | +13.7M (+85.5%) |
| Value | $45.5M | $148.2M | +$102.6M (+225.4%) |
New holders (10)
Institutions that held AC Immune SA at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Redmile Group, LLC | 2,000,000 | $10.0M | 0.36% |
| StemPoint Capital LP | 434,588 | $2.17M | 0.59% |
| FMR LLC | 27,202 | $136.0K | 0.00% |
| Goldman Sachs Group Inc | 17,290 | $86.5K | 0.00% |
| Nixon Peabody Trust Co | 12,850 | $64.3K | 0.01% |
| Virtu Financial LLC | 11,552 | $58.0K | 0.00% |
| China Universal Asset Management Co., Ltd. | 9,674 | $48.4K | 0.01% |
| BNP Paribas Arbitrage, SA | 2,669 | $13.3K | 0.00% |
| Citigroup Inc | 1,514 | $7.57K | 0.00% |
| Bank of America Corp | 258 | $1.29K | 0.00% |
Sold out (6)
Institutions that held AC Immune SA at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Susquehanna International Group, LLP | 71,487 | $203.7K |
| Cohen Lawrence B | 12,850 | $36.6K |
| Group One Trading, L.P. | 5,255 | $15.0K |
| Citadel Advisors LLC | 1,097 | $3.13K |
| Simplex Trading, LLC | 553 | $1.00K |
| Qube Research & Technologies Ltd | 186 | $530 |